Author

Olivia M. Vetterlein

Observed names: O Vetterlein, Olivia Vetterlein, VETTERLEIN, O

OpenAlex ID: A5014599367

Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses.

1995 · S Stephens, S Emtage, et al. · PubMed · 124

The S228P Mutation Prevents in Vivo and in Vitro IgG4 Fab-arm Exchange as Demonstrated using a Combination of Novel Quantitative Immunoassays and Physiological Matrix Preparation

2015 · John-Paul Silva, Olivia Vetterlein, et al. · Journal of Biological Chemistry · 94

F(ab′)2 molecules made from Escherichia coli produced Fab′ with hinge sequences conferring increased serum survival in an animal model

1998 · David P. Humphreys, Olivia M. Vetterlein, et al. · Journal of Immunological Methods · 35

The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis.

1999 · E H Choy, E C Rankin, et al. · PubMed · 7

CDP571, An Engineered Antibody to Human Tumor Necrosis Factor

2019 · Sue Stephens, Olivia Vetterlein, et al. · CRC Press eBooks

In Patients Suffering from Crohnʼs Disease, No Cross Reaction between Antibodies to Infliximab and Certolizumab Pegol Was Detected

2006 · Andrew M. Nesbitt, Olivia M. Vetterlein, et al. · The American Journal of Gastroenterology

Serological Effects of Repeated Doses of an Engineered Human Anti-tnf-alpha - Antibody, Cdp571, in Patients With Rheumatoid-arthritis (ra)

1995 · RANKIN, ECC, CHOY, EHS, et al. · UCL Discovery (University College London)

Works count: 7

Citation count: 260

H-index: 4

I10-index: 3